PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
GGR vs. BIOR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GGR and BIOR is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

GGR vs. BIOR

Last updated Jun 1, 2025

Compare and contrast key facts about Gogoro Inc (GGR) and Biora Therapeutics Inc (BIOR).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GGR or BIOR.

Performance

GGR vs. BIOR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Gogoro Inc (GGR) and Biora Therapeutics Inc (BIOR). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

GGR:

-0.92

BIOR:

-0.93

Sortino Ratio

GGR:

-2.19

BIOR:

-2.68

Omega Ratio

GGR:

0.76

BIOR:

0.46

Calmar Ratio

GGR:

-0.84

BIOR:

-0.97

Martin Ratio

GGR:

-1.30

BIOR:

-1.34

Ulcer Index

GGR:

63.32%

BIOR:

72.12%

Daily Std Dev

GGR:

90.08%

BIOR:

103.77%

Max Drawdown

GGR:

-98.65%

BIOR:

-99.99%

Current Drawdown

GGR:

-98.33%

BIOR:

-99.99%

Fundamentals

Market Cap

GGR:

$72.95M

BIOR:

$994.99K

EPS

GGR:

-$0.46

BIOR:

$0.36

PS Ratio

GGR:

0.24

BIOR:

0.74

PB Ratio

GGR:

0.46

BIOR:

0.00

Total Revenue (TTM)

GGR:

$304.43M

BIOR:

$350.00K

Gross Profit (TTM)

GGR:

$6.05M

BIOR:

$240.00K

EBITDA (TTM)

GGR:

-$21.35M

BIOR:

-$12.92M

Returns By Period

GGR

YTD

-50.57%

1M

-4.89%

6M

-60.15%

1Y

-83.08%

3Y*

-63.33%

5Y*

N/A

10Y*

N/A

BIOR

YTD

0.00%

1M

0.00%

6M

-88.72%

1Y

-96.56%

3Y*

-89.84%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Gogoro Inc

Biora Therapeutics Inc

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

GGR vs. BIOR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
GGR
The Risk-Adjusted Performance Rank of GGR is 55
Overall Rank
The Sharpe Ratio Rank of GGR is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of GGR is 11
Sortino Ratio Rank
The Omega Ratio Rank of GGR is 33
Omega Ratio Rank
The Calmar Ratio Rank of GGR is 44
Calmar Ratio Rank
The Martin Ratio Rank of GGR is 1212
Martin Ratio Rank
BIOR
The Risk-Adjusted Performance Rank of BIOR is 44
Overall Rank
The Sharpe Ratio Rank of BIOR is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of BIOR is 11
Sortino Ratio Rank
The Omega Ratio Rank of BIOR is 00
Omega Ratio Rank
The Calmar Ratio Rank of BIOR is 11
Calmar Ratio Rank
The Martin Ratio Rank of BIOR is 1111
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GGR vs. BIOR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Gogoro Inc (GGR) and Biora Therapeutics Inc (BIOR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GGR Sharpe Ratio is -0.92, which is comparable to the BIOR Sharpe Ratio of -0.93. The chart below compares the historical Sharpe Ratios of GGR and BIOR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

GGR vs. BIOR - Dividend Comparison

Neither GGR nor BIOR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

GGR vs. BIOR - Drawdown Comparison

The maximum GGR drawdown since its inception was -98.65%, roughly equal to the maximum BIOR drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for GGR and BIOR.

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

GGR vs. BIOR - Volatility Comparison

Gogoro Inc (GGR) has a higher volatility of 18.11% compared to Biora Therapeutics Inc (BIOR) at 0.00%. This indicates that GGR's price experiences larger fluctuations and is considered to be riskier than BIOR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...

Financials

GGR vs. BIOR - Financials Comparison

This section allows you to compare key financial metrics between Gogoro Inc and Biora Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.0020.00M40.00M60.00M80.00M100.00M120.00M20212022202320242025
63.62M
32.00K
(GGR) Total Revenue
(BIOR) Total Revenue
Values in USD except per share items